A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition program in human cells, may provide an effective approach for treating triple-negative breast cancer.
Fuente : http://www.eurekalert.org/pub_releases/2014-02/uok...
Fuente : http://www.eurekalert.org/pub_releases/2014-02/uok...